LFCR logo

Lifecore Biomedical (LFCR) Return On Equity

Annual ROE

339.11%
+577.32%+242.36%

May 26, 2024

Summary

Performance

1-Year Change

+242.36%

3-Year Change

+2377.43%

5-Year Change

+211843.75%

15-Year Change

+6950.1%

LFCR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.2%
LFCR annual return on equity is higher than 96.2% of companies in Healthcare sector

High & Low

All-time High

339.11%
LFCR annual return on equity is currently at an all-time high

3-Year Low

-238.21%

Earnings dates

Last Annual Earnings Report Date

May 26, 2024
LFCR previous annual earnings announcement was published on May 26, 2024

Next Annual Earnings Report Date

N/A
LFCR next annual earnings announcement has not yet been scheduled

OtherLFCRprofitabilitymetrics:

Annual Revenue

$128.26 M
LFCR annual revenue is $128.26 million

Annual Net Income

$12.01 M
LFCR annual net profit is $12.01 million

Annual EPS

$0.32
LFCR annual earnings per share is $0.32

Annual ROA

4.73%
LFCR annual return on assets is 4.73%

Quarterly ROE

-169.94%
-422.84%-167.20%

November 24, 2024

Summary

Performance

3-Month Change

-167.2%

1-Year Change

+40.19%

3-Year Change

+40.19%

5-Year Change

-4075.43%

LFCR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.77%
LFCR quarterly return on equity is higher than 14.77% of companies in Healthcare sector

High & Low

All-time High

475.50%
LFCR quarterly return on equity is currently -135.74% below its historical high of 475.50%

3-Year Low

-393.06%

Earnings dates

Last Quarterly Earnings Report Date

Nov 24, 2024
LFCR previous earnings announcement was published on Nov 24, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
LFCR next earnings announcement is scheduled for Apr 8, 2025

OtherLFCRprofitabilitymetrics:

Quarterly Revenue

$32.56 M
LFCR quarterly revenue is $32.56 million

Quarterly Net Income

-$6.57 M
LFCR quarterly net profit is -$6.57 million

Quarterly EPS

-$0.25
LFCR quarterly earnings per share is -$0.25

Quarterly ROA

-5.71%
LFCR quarterly return on assets is -5.71%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

339.11%
LFCR annual return on equity is 339.11%

Annual Net Income

$12.01 M
LFCR annual net profit is $12.01 million

Annual Shareholders Equity

$11.31 M
LFCR annual stockholders equity is $11.31 million

LFCR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+242.4%+40.2%
3 y3 years+2377.4%+40.2%
5 y5 years+10000.0%-4075.4%

LFCR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+242.4%-135.7%+56.8%
5 y5-yearat high+242.4%-135.7%+56.8%
alltimeall timeat high+242.4%-135.7%+56.8%

Lifecore Biomedical ROE History

DateAnnualQuarterly
Nov 2024
-
-169.94%(-167.2%)
Aug 2024
-
252.90%(-46.8%)
May 2024
339.11%(-242.4%)
475.50%(-267.3%)
Feb 2024
-
-284.15%(-27.7%)
Nov 2023
-
-393.06%(+48.3%)
Aug 2023
-
-264.96%(+53.8%)
May 2023
-238.21%(+196.5%)
-172.33%(+30.0%)
Feb 2023
-
-132.53%(+60.3%)
Nov 2022
-
-82.67%(-5.0%)
Aug 2022
-
-86.98%(+17.1%)
May 2022
-80.33%(+439.5%)
-74.29%(+110.9%)
Feb 2022
-
-35.22%(+21.7%)
Nov 2021
-
-28.93%(+93.9%)
Aug 2021
-
-14.92%(-1.3%)
May 2021
-14.89%(-2.3%)
-
May 2021
-
-15.11%(-25.1%)
Feb 2021
-
-20.18%(-7.5%)
Nov 2020
-
-21.82%(+20.3%)
Aug 2020
-
-18.14%(+20.9%)
May 2020
-15.24%(-9625.0%)
-15.00%(+68.9%)
Feb 2020
-
-8.88%(+118.2%)
Nov 2019
-
-4.07%(+133.9%)
Aug 2019
-
-1.74%(-1187.5%)
May 2019
0.16%(-98.5%)
0.16%(-94.0%)
Feb 2019
-
2.65%(-69.8%)
Nov 2018
-
8.77%(-6.4%)
Aug 2018
-
9.37%(-9.8%)
May 2018
10.33%(+114.8%)
10.39%(+14.4%)
Feb 2018
-
9.08%(+140.2%)
Nov 2017
-
3.78%(-10.2%)
Aug 2017
-
4.21%(-12.5%)
May 2017
4.81%(-189.4%)
4.81%(-19.3%)
Feb 2017
-
5.96%(-209.2%)
Nov 2016
-
-5.46%(+5.2%)
Aug 2016
-
-5.19%(-2.8%)
May 2016
-5.38%(-184.3%)
-5.34%(-4.1%)
Feb 2016
-
-5.57%(-195.5%)
Nov 2015
-
5.83%(-11.1%)
Aug 2015
-
6.56%(+2.7%)
May 2015
6.38%(-35.8%)
6.39%(-4.5%)
Feb 2015
-
6.69%(-17.9%)
Nov 2014
-
8.15%(-3.9%)
Aug 2014
-
8.48%(-14.9%)
May 2014
9.94%(-27.0%)
9.97%(-3.0%)
Feb 2014
-
10.28%(+5.5%)
Nov 2013
-
9.74%(-26.8%)
Aug 2013
-
13.30%(-2.3%)
May 2013
13.61%(+55.0%)
13.61%(+4.3%)
Feb 2013
-
13.05%(-3.9%)
Nov 2012
-
13.58%(+31.8%)
Aug 2012
-
10.30%(+17.3%)
May 2012
8.78%(+202.8%)
8.78%(+74.2%)
Feb 2012
-
5.04%(+50.0%)
Nov 2011
-
3.36%(+36.0%)
Aug 2011
-
2.47%(-13.6%)
May 2011
2.90%
2.86%(-24.9%)
Feb 2011
-
3.81%(+10.8%)
Nov 2010
-
3.44%(+11.3%)
DateAnnualQuarterly
Aug 2010
-
3.09%(+1.6%)
May 2010
3.07%(-51.7%)
3.04%(-46.2%)
Feb 2010
-
5.65%(+0.9%)
Nov 2009
-
5.60%(-1.2%)
Aug 2009
-
5.67%(-10.6%)
May 2009
6.36%(-46.4%)
6.34%(-22.0%)
Feb 2009
-
8.13%(-22.3%)
Nov 2008
-
10.46%(-15.8%)
Aug 2008
-
12.43%(-3.3%)
May 2008
11.87%(-59.6%)
12.86%(-6.4%)
Feb 2008
-
13.74%(-60.5%)
Nov 2007
-
34.78%(+6.2%)
Aug 2007
-
32.75%(+8.1%)
May 2007
29.35%(+172.0%)
30.30%(-13.5%)
Feb 2007
-
35.02%(+181.5%)
Nov 2006
-
12.44%(+8.5%)
Aug 2006
-
11.47%(+2.6%)
May 2006
10.79%(+36.4%)
11.18%(+25.6%)
Feb 2006
-
8.90%(+18.2%)
Nov 2005
-
7.53%(-7.0%)
Aug 2005
-
8.10%(+0.1%)
May 2005
7.91%(+66.5%)
8.09%(-0.5%)
Feb 2005
-
8.13%(+38.3%)
Nov 2004
-
5.88%(+24.6%)
Aug 2004
-
4.72%(-3.5%)
May 2004
4.75%(+54.7%)
4.89%(-11.4%)
Feb 2004
-
5.52%(+636.0%)
Nov 2003
-
0.75%(-148.7%)
Aug 2003
-
-1.54%(+19.4%)
May 2003
3.07%(-212.0%)
-
Apr 2003
-
-1.29%(<-9900.0%)
Jan 2003
-
0.00%(-100.0%)
Oct 2002
-2.74%(-92.4%)
-2.69%(-90.4%)
Jul 2002
-
-28.16%(-8.0%)
Apr 2002
-
-30.60%(-15.9%)
Jan 2002
-
-36.38%(+0.1%)
Oct 2001
-36.02%(+152.4%)
-36.36%(+221.5%)
Jul 2001
-
-11.31%(+17.3%)
Apr 2001
-
-9.64%(-5.4%)
Jan 2001
-
-10.19%(+20.9%)
Oct 2000
-14.27%(-15.6%)
-8.43%(-31.5%)
Jul 2000
-
-12.31%(-27.2%)
Apr 2000
-
-16.90%(-3.6%)
Jan 2000
-
-17.53%(+8.5%)
Oct 1999
-16.91%(+102.0%)
-16.16%(+106.1%)
Jul 1999
-
-7.84%(+37.1%)
Apr 1999
-
-5.72%(-31.8%)
Jan 1999
-
-8.39%(+1.8%)
Oct 1998
-8.37%(-64.9%)
-8.24%(+43.6%)
Jul 1998
-
-5.74%(+16.0%)
Apr 1998
-
-4.95%(-81.1%)
Jan 1998
-
-26.15%(+5.0%)
Oct 1997
-23.82%(+102.7%)
-24.90%(+0.4%)
Jul 1997
-
-24.81%(+4.0%)
Apr 1997
-
-23.86%(+102.4%)
Jan 1997
-
-11.79%(+4.1%)
Oct 1996
-11.75%
-11.33%(+75.1%)
Jul 1996
-
-6.47%(+68.5%)
Apr 1996
-
-3.84%

FAQ

  • What is Lifecore Biomedical annual return on equity?
  • What is the all time high annual ROE for Lifecore Biomedical?
  • What is Lifecore Biomedical annual ROE year-on-year change?
  • What is Lifecore Biomedical quarterly return on equity?
  • What is the all time high quarterly ROE for Lifecore Biomedical?
  • What is Lifecore Biomedical quarterly ROE year-on-year change?

What is Lifecore Biomedical annual return on equity?

The current annual ROE of LFCR is 339.11%

What is the all time high annual ROE for Lifecore Biomedical?

Lifecore Biomedical all-time high annual return on equity is 339.11%

What is Lifecore Biomedical annual ROE year-on-year change?

Over the past year, LFCR annual return on equity has changed by +577.32% (+242.36%)

What is Lifecore Biomedical quarterly return on equity?

The current quarterly ROE of LFCR is -169.94%

What is the all time high quarterly ROE for Lifecore Biomedical?

Lifecore Biomedical all-time high quarterly return on equity is 475.50%

What is Lifecore Biomedical quarterly ROE year-on-year change?

Over the past year, LFCR quarterly return on equity has changed by +114.21% (+40.19%)